Keywords: vertex, cf, drug, boosts, fev1, g551d, patients

Vertex' CF drug boosts FEV1 in G551D patients

Article | 27 October 2008

Print This

The USA's Vertex Pharmaceuticals has reported positive results from a preliminary analysis of data from the second stage of the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in